Christopher Marano

1.1k total citations · 1 hit paper
13 papers, 748 citations indexed

About

Christopher Marano is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Neurology. According to data from OpenAlex, Christopher Marano has authored 13 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 3 papers in Cognitive Neuroscience and 2 papers in Neurology. Recurrent topics in Christopher Marano's work include Dementia and Cognitive Impairment Research (7 papers), Schizophrenia research and treatment (4 papers) and Healthcare Decision-Making and Restraints (2 papers). Christopher Marano is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Schizophrenia research and treatment (4 papers) and Healthcare Decision-Making and Restraints (2 papers). Christopher Marano collaborates with scholars based in United States, Canada and Japan. Christopher Marano's co-authors include Constantine G. Lyketsos, Paul B. Rosenberg, Cynthia A. Munro, Daniel Weintraub, Lon S. Schneider, Anton P. Porsteinsson, Bruce G. Pollock, Jacobo Mintzer, Peter V. Rabins and Constantine Frangakis and has published in prestigious journals such as JAMA, PLoS ONE and Journal of Affective Disorders.

In The Last Decade

Christopher Marano

12 papers receiving 720 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Citalopram on Agitation in Alzheimer Disease

2014 353 citations Anton P. Porsteinsson, Lea T. Drye et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Marano United States	9	502	207	140	94	85	13	748
David M. Marks United States	15	345 0.7×	163 0.8×	220 1.6×	77 0.8×	67 0.8×	29	953
Maosheng Fang China	15	523 1.0×	264 1.3×	141 1.0×	214 2.3×	146 1.7×	29	974
Thomas J. Arndt United States	8	760 1.5×	105 0.5×	171 1.2×	71 0.8×	147 1.7×	8	1.1k
Alma Mihaljević-Peleš Croatia	19	390 0.8×	115 0.6×	149 1.1×	78 0.8×	175 2.1×	58	943
Donald P. Hay United States	13	594 1.2×	82 0.4×	210 1.5×	47 0.5×	113 1.3×	27	802
J Rasmussen United Kingdom	9	362 0.7×	99 0.5×	235 1.7×	34 0.4×	46 0.5×	21	782
M. Andrew Berisford United States	9	852 1.7×	402 1.9×	212 1.5×	169 1.8×	149 1.8×	11	1.2k
Philipp Rothe Germany	10	1.1k 2.1×	119 0.6×	242 1.7×	74 0.8×	234 2.8×	17	1.4k
Fabricio Ferreira de Oliveira Brazil	21	443 0.9×	361 1.7×	100 0.7×	27 0.3×	29 0.3×	63	862
Bruno Agustini Australia	13	203 0.4×	85 0.4×	101 0.7×	64 0.7×	104 1.2×	23	915

Countries citing papers authored by Christopher Marano

Since Specialization

Citations

This map shows the geographic impact of Christopher Marano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Marano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Marano more than expected).

Fields of papers citing papers by Christopher Marano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Marano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Marano. The network helps show where Christopher Marano may publish in the future.

Co-authorship network of co-authors of Christopher Marano

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Marano. A scholar is included among the top collaborators of Christopher Marano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Marano. Christopher Marano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Doddi, Seshagiri, et al.. (2025). Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination. Journal of Clinical Psychopharmacology. 45(2). 160–162.

Doddi, Seshagiri, Christopher Marano, William T. Regenold, et al.. (2023). Evaluating salvage electroconvulsive therapy for the treatment of prolonged super refractory status epilepticus: A case series. Epilepsy & Behavior. 144. 109286–109286. 5 indexed citations

Nowrangi, Milap A., Christopher Marano, Kenichi Oishi, et al.. (2020). The association of neuropsychiatric symptoms with regional brain volumes from patients in a tertiary multi-disciplinary memory clinic. International Psychogeriatrics. 33(3). 233–244. 10 indexed citations

Sakamoto, Ryo, Christopher Marano, Michael I. Miller, et al.. (2019). Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening. Journal of Healthcare Engineering. 2019. 1–10. 5 indexed citations

Weintraub, Daniel, Lea T. Drye, Anton P. Porsteinsson, et al.. (2015). Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. American Journal of Geriatric Psychiatry. 23(11). 1127–1133. 19 indexed citations

Rosenberg, Paul B., Lea T. Drye, Anton P. Porsteinsson, et al.. (2015). Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. International Psychogeriatrics. 27(12). 2059–2067. 21 indexed citations

Drye, Lea T., David Spragg, D. P. Devanand, et al.. (2014). Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial. PLoS ONE. 9(6). e98426–e98426. 51 indexed citations

Porsteinsson, Anton P., Lea T. Drye, Bruce G. Pollock, et al.. (2014). Effect of Citalopram on Agitation in Alzheimer Disease. JAMA. 311(7). 682–682. 353 indexed citations breakdown →

Thambisetty, Madhav, E. Jeffrey Metter, Yang An, et al.. (2013). Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging. JAMA Neurology. 70(9). 1167–1167. 125 indexed citations

10.

Marano, Christopher, Clifford I. Workman, Christopher H. Lyman, et al.. (2013). Cortical Beta-Amyloid Deposition in Late-Life Depression. American Journal of Geriatric Psychiatry. 21(3). S127–S127. 4 indexed citations

11.

Drye, Lea T., Zahinoor Ismail, Anton P. Porsteinsson, et al.. (2012). Citalopram for agitation in Alzheimer's disease: Design and methods. Alzheimer s & Dementia. 8(2). 121–130. 44 indexed citations

12.

Dixon, Lisa B., Julie Kreyenbuhl, Faith Dickerson, et al.. (2004). A Comparison of Type 2 Diabetes Outcomes Among Persons With and Without Severe Mental Illnesses. Psychiatric Services. 55(8). 892–900. 92 indexed citations

13.

Regenold, William T., et al.. (2004). Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites—a pilot study in treatment-resistant affective disorder patients. Journal of Affective Disorders. 85(3). 341–350. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact